Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03308942 |
| Title | Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Whittier | Alaska | 90603 | United States | Details | |
| GSK Investigational Site | Port Saint Lucie | Florida | 34952 | United States | Details | |
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Harvey | Illinois | 60426 | United States | Details | |
| GSK Investigational Site | Tinley Park | Illinois | 60487 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
| GSK Investigational Site | Florham Park | New Jersey | 07932 | United States | Details | |
| GSK Investigational Site | Buffalo | New York | 14263 | United States | Details | |
| GSK Investigational Site | Durham | North Carolina | 27710 | United States | Details | |
| GSK Investigational Site | Canton | Ohio | 44718 | United States | Details | |
| GSK Investigational Site | Cleveland | Ohio | 44106 | United States | Details | |
| GSK Investigational Site | Columbus | Ohio | 31904 | United States | Details | |
| GSK Investigational Site | Toledo | Ohio | 43623 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Kennewick | Washington | 99336 | United States | Details | |
| GSK Investigational Site | Tacoma | Washington | 98405 | United States | Details |